Therapeutic index for local infections score (TILI): a new diagnostic tool.

TILI score antiseptic wound decolonisation antiseptic wound therapy hard-to-heal wounds local wound infection

Journal

Journal of wound care
ISSN: 0969-0700
Titre abrégé: J Wound Care
Pays: England
ID NLM: 9417080

Informations de publication

Date de publication:
02 Dec 2020
Historique:
entrez: 15 12 2020
pubmed: 16 12 2020
medline: 2 7 2021
Statut: ppublish

Résumé

Local wound infections are a major challenge for patients and health professionals. Various diagnostic and therapeutic options are available. However, a generally accepted standard is still lacking in Europe. The aim was to develop an easy-to-use clinical score for the early detection of local wound infections, as a basis for decision-making on antiseptic therapy or decolonisation. An interdisciplinary and interprofessional panel of experts from seven European countries was brought together to discuss the various aspects of diagnosing local wound infections. The result was the adoption of the Therapeutic Index for Local Infections (TILI) score, developed in Germany by Initiative Chronische Wunden e.V., specifically for health professionals not specialised in wound care. Available in six European languages, the TILI score could also be adapted for different European countries, depending on their specific national healthcare requirements. The six clinical criteria for local wound infection are erythema to surrounding skin; heat; oedema, induration or swelling; spontaneous pain or pressure pain; stalled wound healing; and increase and/or change in colour or smell of exudate. Meeting all criteria indicates that antiseptic wound therapy could be started. Regardless of these unspecific clinical signs, there are also health conditions for the clinical situation which are a direct indication for antimicrobial wound therapy. These include the presence of wound pathogens, such as meticillin-resistant The development of the new internationally adapted TILI score, which could also be used by any caregiver in daily practice to diagnose local infections in acute and hard-to-heal wounds, is the result of expert consensus. However, the score system has to be validated through a clinical evaluation. This is to be performed in expert centres throughout Europe.

Identifiants

pubmed: 33320745
doi: 10.12968/jowc.2020.29.12.720
doi:

Types de publication

Journal Article

Langues

eng

Pagination

720-726

Auteurs

Joachim Dissemond (J)

Department for Dermatology, Venerology and Allergology, University School of Medicine, Essen, Germany.

Veronika Gerber (V)

ICW (Initiative Chronische Wunden) e.V., Quedlinburg, Germany.

Ralf Lobmann (R)

Department for Endocrinology, Diabetology and Geriatrics, Klinikum Stuttgart - Bad Cannstatt, Germany.

Axel Kramer (A)

Institute of Hygiene and Environmental Medicine, University Medicine Greifswald, Germany.

Diego Mastronicola (D)

Outpatient Wound Care Centre, Local Health Care System Frosinone, Frosinone, Italy.

Eric Senneville (E)

Department of Infectious Diseases, Tourcoing Hospital, France.

Cécile Moisan (C)

Department of Vascular and Endocrinology Surgery, Hopital Yves Le Foll St-Brieuc, France.

Valerie Edwards-Jones (V)

Department of Medical Microbiology, Manchester Metropolitan University, UK.

Kirsty Mahoney (K)

Department of Wound Healing, Welsh Wounds Innovation Centre, Primary, Community and Intermediate Care Division, Rhondda Cynon Taf, UK.

Adam Junka (A)

Department of Pharmaceutical Microbiology and Parasitology, Wroclaw Medical University, Poland.

Marzenna Bartoszewicz (M)

Department of Pharmaceutical Microbiology and Parasitology, Wroclaw Medical University, Poland.

José Verdú-Soriano (J)

Department of Community Nursing, Preventive Medicine, Public Health and History of Science, Faculty of Health Sciences, University of Alicante, Alicante, Spain.

Robert Strohal (R)

Department of Dermatology and Venerology, Federal Academic Teaching Hospital, Feldkirch, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH